ArticleRSC advances2022
Thiazolidinedione derivatives as novel GPR120 agonists for the treatment of type 2 diabetes.
Xuekun Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleRSC advances2022
Xuekun Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.